Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Freeman

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|April 7, 1972
Argonne's RoleS D Freeman
Bone Marrow Transplantation|January 17, 2017
Professor David Grimwade (1962-2016)N H Russell, S D Freeman, C Craddock
Blood|April 15, 1995
Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction moleculesS D Freeman, S Kelm, E K Barber, et al.
The Journal of Biological Chemistry|April 17, 1999
The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2V C Taylor, C D Buckley, M Douglas, et al.
Nuclear Medicine and Biology|April 11, 2001
Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumorsM Muzi, S D Freeman, R C Burrows, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Feasibility of imaging pentose cycle glucose metabolism in gliomas with PET: studies in rat brain tumor modelsA M Spence, M M Graham, M Muzi, et al.
Leukemia|November 1, 2016
Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemiaN Khan, R K Hills, P Virgo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 7, 1998
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constantA M Spence, M Muzi, M M Graham, et al.
Leukemia|November 27, 2014
Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemiaC Bradbury, A E Houlton, S Akiki, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2000
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophilsK K Kikly, B S Bochner, S D Freeman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|April 7, 1972
Argonne's RoleS D Freeman
Bone Marrow Transplantation|January 17, 2017
Professor David Grimwade (1962-2016)N H Russell, S D Freeman, C Craddock
Blood|April 15, 1995
Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction moleculesS D Freeman, S Kelm, E K Barber, et al.
The Journal of Biological Chemistry|April 17, 1999
The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2V C Taylor, C D Buckley, M Douglas, et al.
Nuclear Medicine and Biology|April 11, 2001
Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumorsM Muzi, S D Freeman, R C Burrows, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Feasibility of imaging pentose cycle glucose metabolism in gliomas with PET: studies in rat brain tumor modelsA M Spence, M M Graham, M Muzi, et al.
Leukemia|November 1, 2016
Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemiaN Khan, R K Hills, P Virgo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 7, 1998
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constantA M Spence, M Muzi, M M Graham, et al.
Leukemia|November 27, 2014
Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemiaC Bradbury, A E Houlton, S Akiki, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2000
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophilsK K Kikly, B S Bochner, S D Freeman, et al.
Pageof 1